解脲支原体感染孕妇对妊娠结局影响与预防措施分析

Influence of Ureaplasma urealyticum infection in pregnant women on pregnancy outcomes and analysis of preventive measures

  • 摘要: 目的 探讨和分析解脲支原体感染孕妇对妊娠结局的影响及其相关预防措施。方法 选取2015年7月-2017年6月医院所收治的327例分娩产妇作为本次临床研究对象,通过产前宫颈分泌物解脲支原体检测结果将98例阳性者设为试验组,229例阴性者设为对照组,并分别对本次临床研究中解脲支原体感染孕妇对妊娠结局的影响及其相关预防措施予以全面深入的探讨和分析。结果 试验组解脲支原体感染患者早产的发生率19.39%和胎膜早破的发生率35.71%,均高于对照组的6.99%、13.97%(P<0.05);试验组解脲支原体感染患者发生低出生体重儿的发生率为10.20%,新生儿黄疸发生率为14.29%,新生儿肺炎发生率为9.18%,均高于对照组的4.37%、6.11%、2.62%(P<0.05)。结论 解脲支原体感染增加了孕妇不良妊娠结局,并对围生儿健康造成了一定的影响,临床上应给予积极的预防干预措施保障孕妇及围生儿安全。

     

    Abstract: OBJECTIVE To explore and analyze the influence of Ureaplasma urealyticum infection in pregnant women on pregnancy outcomes and related preventive measures. METHODS A total of 327 parturient women giving birth in the hospital from Jul. 2015 to Jun. 2017 were selected as the subjects in the clinical study. According to the U urealyticum test results of the prenatal cervical secretions, 98 cases with positive results were set as the observation group and 229 cases with negative results were set as the control group. The influence of U urealyticum infection in pregnant women on pregnancy outcomes and related preventive measures were comprehensively and deeply explored and analyzed. RESULTS The premature delivery rate was 19.39% (19/98) and rate of premature rupture of membranes was 35.71% (35/98) in the patients with ureaplasma urealyticum infection in the observation group, significantly higher than those of the control group (6.99% and 13.97%)(P<0.05). In the patients with U urealyticum infection in the observation group, the incidence of low birth weight infants was 10.20% (10/98), neonatal jaundice was 14.29% (14/98), neonatal pneumonia was 9.18% (9/98), which were significantly higher than those of the control group (4.37%, 6.11% and 2.62%) (P<0.05). CONCLUSION U urealyticum infection in pregnant women could increase the adverse pregnancy outcomes, and has certain impact on the perinatal health. In clinical, positive preventive interventions should be given to ensure the safety of pregnant women and perinatal infants.

     

/

返回文章
返回